Matthias Scheffler - Concepedia

Author

Matthias Scheffler

Also Known As

L. Gogl, M Scheffler, M. Scheffler, Matthias Scheffler, Matthias Scheffler Matthias Scheffler, Morgan Scheffler, Scheffler, M.

438

Publications

7.7K

Citations

H-Index

110

Concepts

All Affiliations

University Hospital Cologne University of Cologne Fritz Haber Institute of the Max Planck Society Krankenhaus Bethanien University Hospital Frankfurt

About

Matthias Scheffler is an author at University Hospital Cologne specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	2.4K
2	Engineering	12	13	734
3	Health Sciences	6	6	414
4	Natural Sciences	6	6	351
5	Arts	1	1	18

Matthias Scheffler

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls Andreas Keller, Petra Leidinger, Julia Lange, PLoS ONE Disease ProgressionImmunologyPathologyHealthy ControlsNeurology	2009	364
Toward the blood-borne miRNome of human diseases Andreas Keller, Petra Leidinger, Andrea S. Bauer, Nature Methods Disease MechanismMedicinePathogenesisPathologyBlood-borne Mirnome	2011	360
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors Sandra Ortiz‐Cuaran, Matthias Scheffler, Dennis Plenker, Clinical Cancer Research	2016	259
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways Matthias Scheffler, Michaela A. Ihle, Rebecca Hein, Journal of Thoracic Oncology	2018	247
Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors Paola Di Gion, Friederike Kanefendt, Andreas Lindauer, Clinical Pharmacokinetics Medicinal ChemistryMedicineClinical PharmacokineticsPharmacologyPharmacokinetics	2011	214
Pseudopotential study of binding properties of solids within generalized gradient approximations: The role of core-valence exchange correlation Martin Fuchs, Michel Bockstedte, E. Pehlke, Physical review. B, Condensed matter	1998	209
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer Anna Kron, Christina Alidousty, Matthias Scheffler, Annals of Oncology	2018	207
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort Oliver Gautschi, Julie Milia, Bastien Cabarrou, Journal of Thoracic Oncology MedicinePathologyEuropean Euraf CohortImmune Checkpoint InhibitorBronchial Neoplasm	2015	186
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening Sebastian Häusler, Andreas Keller, P. Anoop Chandran, British Journal of Cancer	2010	179
Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [<sup>18</sup>F]Fluorodeoxyglucose and [<sup>18</sup>F]Fluorothymidine Positron Emission Tomography Thomas Zander, Matthias Scheffler, Lucia Nogová, Journal of Clinical Oncology	2011	171

Page 1